Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA preparing guidance to tackle COVID-19 variants 10 February 2021NewsHumanCOVID-19MedicinesVaccines Clarification on Sputnik V vaccine in the EU approval process 10 February 2021NewsHumanCOVID-19Vaccines International regulators working together to enhance collaboration on COVID-19 observational research 8 February 2021NewsHumanCOVID-19MedicinesVaccines EMA reviewing data on monoclonal antibody use for COVID-19 4 February 2021NewsHumanCOVID-19Medicines EMA COVID-19 assessments ‘OPEN’ to non-EU regulators 4 February 2021NewsHumanCOVID-19MedicinesVaccines EMA starts rolling review of Novavax’s COVID-19 vaccine (NVX-CoV2373) 3 February 2021NewsHumanCOVID-19MedicinesVaccines EMA starts rolling review of REGN-COV2 antibody combination (casirivimab / imdevimab) 1 February 2021NewsHumanCOVID-19Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-29 January 2021 1 February 2021NewsHumanBiosimilarsGeneric and hybrid medicinesMedicines EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU 29 January 2021NewsHumanCOVID-19MedicinesVaccines First COVID-19 vaccine safety update published 29 January 2021NewsHumanCOVID-19MedicinesVaccines 1 … 68 69 70 71 72 Page 72 of 380 73 74 75 76 … 380
EMA preparing guidance to tackle COVID-19 variants 10 February 2021NewsHumanCOVID-19MedicinesVaccines
Clarification on Sputnik V vaccine in the EU approval process 10 February 2021NewsHumanCOVID-19Vaccines
International regulators working together to enhance collaboration on COVID-19 observational research 8 February 2021NewsHumanCOVID-19MedicinesVaccines
EMA COVID-19 assessments ‘OPEN’ to non-EU regulators 4 February 2021NewsHumanCOVID-19MedicinesVaccines
EMA starts rolling review of Novavax’s COVID-19 vaccine (NVX-CoV2373) 3 February 2021NewsHumanCOVID-19MedicinesVaccines
EMA starts rolling review of REGN-COV2 antibody combination (casirivimab / imdevimab) 1 February 2021NewsHumanCOVID-19Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-29 January 2021 1 February 2021NewsHumanBiosimilarsGeneric and hybrid medicinesMedicines
EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU 29 January 2021NewsHumanCOVID-19MedicinesVaccines